Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies - Wikidata - thesis-toulmin - TriplyDB

Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies

Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies

http://www.wikidata.org/entity/Q28546587

about

Current Trends in Multidrug Optimization.

P2860

Q39016850-1B71BA26-A045-4785-AB6C-CF0CD0814753

P2860

Discovering anti-platelet drug combinations with an integrated model of activator-inhibitor relationships, activator-activator synergies and inhibitor-inhibitor synergies

http://www.wikidata.org/entity/Q28546587

description

2015 nî lūn-bûn

@nan

2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@ast

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@en

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@nl

type

label

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@ast

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@en

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@nl

prefLabel

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@ast

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@en

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@nl

P1433

Q28546587-CC2078D3-95B2-45CF-A3E7-548CA93F56AA

P1476

Q28546587-DC6C169E-A8A8-4142-93F1-4CD996FD51AA

P2093

Q28546587-42A09B61-6C39-4AAE-B784-2849A6E73089

Q28546587-6CEBBD8A-5233-44C3-BF11-6D9F91B9C992

Q28546587-8249C82C-D222-4FD0-8CE3-D5146783AFBD

Q28546587-8E10CFAC-CF9E-4EF8-B724-FC4078D794B3

Q28546587-CE772A21-967E-4F6F-93E7-5D1A88360FA6

Q28546587-D9477990-4EF9-4C9F-B55D-7A2E05508EC2

P2860

Q28546587-02124F8E-9ED9-48CE-9738-4D311591454F

Q28546587-0931BCB1-4BE6-4C57-A62C-4CBC374AA162

Q28546587-0B50E029-5226-4A59-8F21-CB56F0EC53F3

Q28546587-1E80160D-174C-4D48-8818-4A7A2D2981B8

Q28546587-211CB781-928D-4A3F-8426-927E20C0128F

Q28546587-239B39B6-196F-4007-AF10-D34EA50B7BFD

Q28546587-30488459-AEB3-49D1-B8B0-617B081FBADA

Q28546587-4D3112DB-F70F-4DE5-A4AA-1E87135031BB

Q28546587-5A840057-BF8E-4FA6-B756-2C58F4691450

Q28546587-68E95A08-D453-4CA5-B7B5-8A64884607A5

P304

Q28546587-5F3D92CC-1ACC-468D-94E4-3216ADD6EFD3

P31

Q28546587-C080A25A-09C5-4063-9548-8887CE341E77

P356

Q28546587-13404ACE-70A7-484E-B31E-216EDA473633

P407

Q28546587-B55CB332-889C-413A-A1BC-189A60B06C9F

P433

Q28546587-36A507BB-35C8-4BC2-8C44-31DD16DE355D

P478

Q28546587-5CF6FAD9-9BE9-4A97-877C-EB72DC4D2809

P577

Q28546587-052D7D17-3047-427C-9AC9-0DCE5690782A

P5875

Q28546587-D751B09E-6D2F-4327-AEAC-EF444BFEA456

P698

Q28546587-BE561A12-2893-4C0B-8BA4-DEDEAA2E89AC

P932

Q28546587-58413B64-245B-454C-A390-2261EE0B9A07

P356

JOURNAL.PCBI.1004119

P1433

PLOS Computational Biology

P1476

Discovering anti-platelet drug ...... inhibitor-inhibitor synergies

@en

P2093

Darren J Fitzpatrick

http://www.w3.org/2001/XMLSchema#string

Denis C Shields

http://www.w3.org/2001/XMLSchema#string

Federica Lombardi

http://www.w3.org/2001/XMLSchema#string

Fergal P Casey

http://www.w3.org/2001/XMLSchema#string

Kalyan Golla

http://www.w3.org/2001/XMLSchema#string

Niamh Moran

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a cDNA for the human prostanoid IP receptor

G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Identification of Galpha13 as one of the G-proteins that couple to human platelet thromboxane A2 receptors

Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways

The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen

Drug combination studies and their synergy quantification using the Chou-Talalay method

Combination chemical genetics

P304

e1004119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PCBI.1004119

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275045795

http://www.w3.org/2001/XMLSchema#string

P698

25875950

http://www.w3.org/2001/XMLSchema#string

P932

4405222

http://www.w3.org/2001/XMLSchema#string